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Background: The multi-domain protein InlB (internalin B) from Listeria monocytogenes is an agonist of the human
receptor tyrosine kinase MET. Only the internalin domain directly interacts with MET. The internalin domain consists
of seven central leucine-rich repeats (LRRs) flanked by an N-terminal helical cap domain and a C-terminal
immunoglobulin-like structure. A potential function of the N-terminal cap in receptor binding could so far not be
demonstrated by deleting the cap, since the cap is also implicated in nucleating folding of the LRR domain.
Results: We generated an InlB variant (YopM-InlB) in which the InlB cap domain was replaced by the unrelated
N-terminal capping structure of the LRR protein YopM from Yersinia enterocolitica. The crystal structure of the
engineered protein shows that it folds properly. Because the first LRR is structurally closely linked to the cap
domain, we exchanged LRR1 along with the cap domain. This resulted in unexpected structural changes extending
to LRR2 and LRR3, which are deeply involved in MET binding. As a consequence, the binding of YopM-InlB to MET
was substantially weaker than that of wild type InlB. The engineered protein was about one order of magnitude less
active in colony scatter assays than wild type InlB.
Conclusions: We obtained a well-behaved InlB variant with an altered N-terminal capping structure through
protein design. The reduced affinity for MET precludes a straightforward interpretation of the results from cell-based
assays. Still, the engineered hybrid protein induced cell scatter, suggesting that the cap is required for folding and
stability of InlB but is not essential for interactions that assemble the signalling-active receptor complex. The cap
swap approach described here is clearly applicable to other L. monocytogenes internalins and other LRR proteins
such as YopM and may yield useful structure/function correlates within this protein family.
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InlB is a surface-associated or secreted protein that medi-
ates uptake of the pathogen Listeria monocytogenes into
normally non-phagocytic cells by specifically stimulating
the receptor tyrosine kinase MET on host cells [1-4]. InlB
consists of an internalin domain, a B-repeat and three
GW domains [5,6]. The internalin domain can be subdi-
vided into an N-terminal helical cap domain, a leucine-
rich repeat domain and an immunoglobulin-like inter-
repeat (IR) domain. The function of most domains in InlB* Correspondence: Hartmut.Niemann@uni-bielefeld.de
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article, unless otherwise stated.has been tested using N-terminal, C-terminal or internal
deletions, or by expression of the isolated respective do-
mains [4,7-14]. Using this approach the biochemical
properties of the cap + LRR fragment, the IR domain,
the B-repeat, the GW1 module and the GW2 + GW3
pair were addressed. These experiments showed that a
cap + LRR fragment is sufficient for MET binding, but
that the IR domain also contacts the receptor and contrib-
utes to MET activation [4,15]. The other domains (B-re-
peat, GW1-GW3) enhance MET activation by binding to
co-receptors other than MET on host cells [7,10,11,14].
In the past, the cap and LRR domains have only been
investigated together as a single unit, which appears rea-
sonable from a structural point of view. In general, LRR
proteins have specialized N- and C-terminal capping
structures adjacent to the LRR domain that are thoughtentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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core of the LRRs from solvent [16]. In InlB, the LRR and
its flanking cap and IR domain share a single hydropho-
bic core, forming the internalin domain [17,18]. Deletion
of the C-terminal capping structure, the IR domain, does
not disturb the structure of the LRR, as InlB241 and
InlB248, two different constructs lacking the IR domain,
yield functional proteins [7,15,17]. Nevertheless the IR
domain contributes significantly to the stability of InlB
towards chemical and thermal denaturation [19]. To the
best of our knowledge, biochemical experiments involv-
ing an internalin LRR domain lacking its N-terminal cap
have not been reported. One would expect that deletion
of the N-terminal cap would result in misfolding and aggre-
gation or degradation of the LRR domain. This assumption
is corroborated by the finding that InlB folds along a polar-
ized pathway from the N- to the C-terminus [20]. An at-
tempt to express a cap-less InlB in E. coli resulted in
insoluble protein [21]. As a consequence, the function in
receptor activation of the cap and the LRR domain of InlB
has so far never been investigated individually.
Results
Generation and biochemical characterization of
YopM-InlB
To address a potential interaction of the InlB cap domain
with a binding partner from the host cell, we sought to re-
place the cap by a structurally unrelated domain that still
initiates folding. YopM is a leucine-rich repeat protein
from Yersinia enterocolitica with 15 LRRs, each 20 or 22
residues in length [22]. The repeats in YopM are most
similar to those of the internalins like InlB [22] and the
overall horseshoe-shaped structure of YopM resembles
that of the 15 LRR internalin InlA [23]. However, the N-
terminal capping structures of L. monocytogenes interna-
lins and Y. eneterocolitica YopM are structurally different.
The cap domain of InlB resembles a truncated EF-hand
motif consisting of three short helices and a two-stranded
antiparallel β-sheet [17,18], while that of YopM consists of
two longer α-helices connected by a single loop [22]. In
InlB the cap is structurally closely linked to the first LRR.
Residues 83 and 91 from LRR1 are alanine and valine in-
stead of leucine or isoleucine in other LRRs. As a conse-
quence, the hydrophobic core of LRR1 is loosely packed
and the side chain of Phe53 from the cap fills the resulting
hole. The capping domain of YopM does not provide a
large side chain to fill the gap in LRR1 of InlB. We thus
reasoned that replacing LRR1 along with the capping do-
main might increase protein stability. This, furthermore,
allowed an EcoRI site in InlB to be used in cloning. The
hybrid protein combines residues 34–87 of YopM with
residues 93–321 of InlB and will be referred to as YopM-
InlB (Figure 1). The protein was produced as GST-fusion
and was purified like the InlB internalin domain (residues36–321, referred to as InlB321) despite having a higher ten-
dency to precipitate. Nevertheless, between 5 and 20 mg
of pure YopM-InlB were obtained per litre of bacterial cul-
ture. The protein eluted as a single symmetric peak from
gel filtration (see below). We used differential scanning
fluorimetry (DSF) to assess the thermal stability of YopM-
InlB and other InlB variants. With a melting temperature
(TM) of 49,9°C (+/−0.22°C) YopM-InlB was destabilized
by about 2 K with respect to InlB321 containing the native
N-terminal cap (TM of 51,9°C (+/− 0.21°C)). YopM-InlB
is considerably more stable than InlB241 (TM of 42,4°C
(+/− 0.51°C)), a truncated form lacking the IR domain,
which acts as C-terminal capping structure [15]. Two
variants with an additional LRR inserted after the first
LRR that bind and activate MET like wild type InlB321
[21] showed melting temperatures close to that of
InlB321 or YopM-InlB (TM of InlB321 + 1LRRa was 52,5°C
(+/−0.08°C); TM of InlB321 + 1LRRb was 49,8°C
(+/−0.16°C)). The results from DSF presented here are
in good agreement with the endothermic denaturation
transitions from differential scanning calorimetry reported
previously for InlB321 (49.8°C) and for InlB248 (42.8°C)
[19]. Small differences between the previous and our re-
sults may be due to different buffers or the different short
InlB constructs (InlB241 vs. InlB248).
Structure of YopM-InlB
We crystallized the YopM-InlB hybrid protein and
solved its structure by molecular replacement. The num-
bering of both fragments in the PDB file corresponds to
that of the proteins from which they were derived. The
gap in numbers between the consecutive residues Pro87
and Gly93 represents the fusion point of Pro87 derived
from YopM and directly adjacent Gly93 derived from
InlB. No residues are actually missing in between.
The structure of YopM-InlB at 1.5 Å resolution (Table 1)
confirms that this designed chimeric protein is properly
folded (Figure 1). The electron density is very well defined
with exception of the N-terminal residues (up to Tyr39),
two residues (Gly53, Asn54) in the loop connecting the
two helices of the YopM cap domain and Glu95 and
Tyr96, the first two residues of InlB directly after the
fusion site. Structural alignment of the N-terminal cap
structure and the first LRR of YopM (residues 34–87 of
PDB ID 1jl5) with the hybrid protein results in an r.m.s.d.
of 0.9 Å for 49 common Cα atoms (0.8 Å for 199 common
main chain atoms; 1.3 Å for all 399 atoms). The largest
deviations are located in the loop region connecting the
two helices (Figure 2A). Structural alignment of InlB321
(PDB ID 1h6t) and the YopM-InlB hybrid protein for the
region comprising residues 93–321 results in a coordinate
r.m.s.d. of 1.0 Å for 223 common Cα atoms (1.0 Å for 901
common main chain atoms; 1.6 Å for all 1775 atoms).
There are major shifts between wild type InlB and the
Figure 1 Design strategy and crystal structure of YopM-InlB. Domain organization of full-length InlB (InlB-fl), InlB321, YopM and the two
hybrid proteins. LRRs are numbered in InlB but not in YopM. The structure of wild type InlB321 (PDB ID 1h6t) is shown on the bottom left. Residues
93–321 are highlighted in green. YopM (PDB ID 1jl5) is shown on the right. Residues 34–87 comprising the cap and LRR1 are highlighted in orange.
The actual crystal structure of the hybrid protein YopM-InlB is shown in the middle.
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For the three surface exposed residues (Gln80, Ile82,
Asn84 in wild type InlB and Glu75, Glu77, Asn79 in
YopM-InlB) the Cα atoms are shifted by 1.2 Å, 2.5 Å
and 2.0 Å, respectively (Figure 2B). The side chains of
InlB Gln80 and Asn84 form hydrogen bonds to Thr646
and His644 of MET, respectively, in the crystal structure
of the InlB:MET complex [15]. Due to their relative shift,
the equivalent atoms in the corresponding residues in
YopM-InlB would no longer be able to form these hydro-
gen bonds (Figure 2C). Moreover, the structural differ-
ences between YopM-InlB and wild type InlB are not
limited to LRR1, which was replaced by the YopM se-
quence. Instead rearrangements extend to LRR2 and to a
lesser extent to LRR3. E.g. the Cα of Phe104, a residue lo-
cated in the β-strand of LRR2 and essential for the binding
of MET [24], is shifted by some 1.5 Å (Figure 2B). We had
not anticipated this medium range effect, which can inretrospect be explained by a slightly lower curvature in
the N-terminal region of the protein due to the absence of
a 310 helix in the first LRR of YopM. With only 20 resi-
dues, (two residues less than a typical internalin LRR) the
first LRR of YopM is among the shortest LRRs known and
it forms an extended rather than a helical structure on the
convex face.
YopM-InlB has reduced affinity for MET
To assess whether the exchange of LRR1 and the unex-
pected structural changes in the β-sheet region of LRR2
and LRR3 impact MET binding, we investigated complex
formation between the MET ectodomain and YopM-InlB
by analytical gel filtration (Figure 3A, Table 2). We com-
pared the elution profile of a stoichiometric 1:1 mixture of
MET and YopM-InlB to that of MET and InlB321. Wild
type InlB321 quantitatively shifted to lower elution volume
indicating formation of a high affinity complex with the
Table 1 Data collection and refinement statistics
Data collection statistics
Beamline DESY X13
Space group C2
Unit cell dimensions [Å], [°] a = 59.21
b = 30.68
c = 135.39
β = 90.98
Resolution [Å] 20-1.50 (1.54-1.50)
Completeness [%] 96.3 (86.1)
Redundancy 3.8 (3.3)
Observations 141243 (6028)
Unique reflections 38095 (2490)
I/σ(I) 13.9 (1.8)
R-meas [%] 6.8 (82.4)
CC(1/2) 99.9 (64.8)
Molecules per asymm. unit 1
Solvent content [%] 35.6 (VM 1.91)
Refinement statistics
Rwork [%] 17.5 (30.3)
Rfree [%] 21.9 (32.5)
Number of atoms total 2512
Protein/solvent/others 2262/250/0
R.m.s. deviation
Bonds [Å] 0.021
Angles [°] 2.218
Ramachandran plot
Residues in favored regions [%] 97.1
Residues in allowed regions [%] 2.9
Residues in disallowed regions [%] 0.0
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trast, the peak for YopM-InlB did not disappear, but was
broadened and became asymmetric (Figure 3A). The ob-
served fronting and the shift to a slightly lower elution
volume indicated weak binding of YopM-InlB to MET and
separation of the complex during the gel filtration run.
Next, we analysed the MET-binding ability of YopM-InlB
in an enzyme-linked immunosorbent assay (ELISA) using
immobilized MET ectodomain and soluble glutathione-S-
transferase (GST)-fusion protein of the two InlB variants
(Figure 3B). Binding affinity of YopM-InlB was strongly
reduced compared to that of InlB321. The titration with
YopM-InlB did not reach saturation at 3 μM, the highest
concentration tested (Figure 3B). This is probably due
to a high off-rate and perturbation of the binding equi-
librium in the washing steps of the ELISA. Thus binding
of YopM-InlB could not be quantitated reliably. How-
ever, our data from gel filtration and ELISA suggest thatthe binding affinity of YopM-InlB for MET may be several
orders of magnitude weaker than that of wild type InlB,
which has an affinity in the low nanomolar range [24,26].
YopM-InlB is at least 10-fold less active in MET
phosphorylation than wild type InlB321
InlB321 is sufficient to induce phosphorylation of MET
and its downstream target ERK [7,15]. Here, we used
ERK phosphorylation as readout for MET activation
(Figure 4A). The shorter construct InlB241 that has the
same affinity for MET as InlB321 but no biological activity
[15] was used as negative control. InlB321 induced ERK
phosphorylation in Vero cells at a concentration of 10−7 M.
Like the negative control InlB241, YopM-InlB remained in-
active even at a tenfold higher concentration. Given the re-
duced affinity of YopM-InlB for MET, this result is not
unexpected. It is presumable due to the significantly lower
affinity for MET.
A YopM-InlB hybrid including the InlB C-terminal
domains induces cell scatter though less efficiently than
wild type InlB
Although InlB321 does stimulate phosphorylation of MET
and ERK, it does not induce cell scatter, in contrast to
full-length InlB (InlB-fl) [4,15,27]. To test whether the
endogenous cap domain of InlB is essential for induc-
tion of a cellular response, we replaced the cap domain
of InlB-fl by that of YopM (YopM-InlB-fl; Figure 1). As
a readout, we used the well-established Madin Darbey
canine kidney (MDCK) cell scatter assay (Figure 4B).
YopM-InlB-fl induced the dispersal of MDCK cell col-
onies down to a concentration of 10−9 M but was in-
active at 10−10 M, the lowest concentration at which
wild type InlB-fl displayed activity. Thus, YopM-InlB-fl
is about one order of magnitude less active than wild
type InlB-fl.
Discussion
The internalin domain is a versatile framework allowing
targeted manipulations
LRR proteins are promising targets for protein engineering
and protein design because of their modular architecture.
Synthetic libraries of designed LRR proteins have been used
as artificial binders that might replace antibodies [28]. Some
of the first structures of toll-like receptors (TLRs) were
obtained with protein chimeras that combine the ligand-
binding LRRs from TLRs with cap structures from vari-
able lymphocyte receptors (VLRs) from hagfish [29]. The
cap swap strategy presented here allows addressing the
biological function of the N-terminal cap of internalins
that cannot be studied with simple domain deletion con-
structs due to its contribution to protein folding. This ap-
proach is not limited to InlB but can similarly be applied
to other internalins, as their cap and LRR domains are
Figure 2 Structural overlay of YopM-InlB with wild type InlB321 and YopM. (A) YopM-InlB is colored orange and green as in Figure 1.
Residues 34–87 from YopM (dark grey) and residues 93–321 from wild type InlB (light grey) are structurally aligned to highlight overall similarity
and local differences. (B) YopM-InlB (colored as in Figure 1 and Figure 2A) was structurally aligned with InlB (grey). LRR1, which carries different
sequences in the two proteins, shows the largest structural deviations. However, residues on the concave face of LRR2 and LRR3 are also shifted.
(C) Overlay of YopM-InlB (colored as in Figure 1 and Figure 2A,B) onto InlB321 (grey) in the complex with MET (brown) (PDB ID 2uzx). Due to the
shift in LRR1 residues Glu75 and Asn79 from YopM-InlB cannot form the hydrogen bonds to MET that are formed by the equivalent residues from
wild type InlB (Gln80 and Asn84, respectively).
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that in protein folding could also be studied for the cap
domain of the Yersinia protein YopM, by reversing the
direction of the domain swap. In a related approach the
cap domain of InlB along with LRR1 and LRR2 was fused
to the ectodomain of VLRs in order to obtain proteins
with favourable physicochemical properties [30].
The InlB cap domain is not essential for MET activation
MET only interacts with the LRR and IR but not with
the cap domain of InlB [15]. The reduced affinity of
YopM-InlB for MET is presumably due to the exchange
of the first LRR along with the cap domain resulting in
spatial shifts of residues from LRR1, LRR2, and LRR3,
whose side chains are involved in MET binding. The dif-
ference in affinity for MET between wild type and cap
variant precludes a straightforward interpretation of the
results from cellular assays. The failure of YopM-InlB to
stimulate MET phosphorylation at a 10-fold higher con-
centration than required for InlB321 can presumably be
ascribed to the reduced MET affinity. Still, the colony
scatter experiments allow the conclusion that the cap is
not essential for MET activation, although some contri-
bution to receptor activation cannot be excluded conclu-
sively from our experiments. Previous data had already
shown that mutation of the potential calcium binding
sites in the InlB cap domain has no appreciable effect onMET activation [31]. Our results extend this observation
and show that, as long as a stable protein is formed, the
cap domain as a whole can be replaced without causing
a complete loss of activity.
Comparing the results of MET phosphorylation in-
duced by YopM-InlB with cell scatter induced by YopM-
InlB-fl shows that interaction of the C-terminal domains
with their cellular receptors (i.e. heparan sulfate proteo-
glycans and/or gC1qR in the case of the GW domains
[14,32,33] and an as of yet unidentified receptor for the
B-repeat [11]) and the resulting avidity effect compen-
sate the low affinity for the MET ectodomain at least
partially. This resembles observations made with mul-
tiple arginine mutations preventing formation of an InlB
dimer contact required for MET dimerization and acti-
vation. These mutations resulted in a more drastic effect
in the isolated internalin domain (InlB321) than in InlB-fl
[27]. One might conclude that interaction of various
InlB domains with multiple host cell receptors endues
InlB with a built-in redundancy that is able to offset a
loss of affinity in one of the domains.
Outlook
The modular design of LRR proteins does not only make
them prime targets of rational protein design, but also
renders them attractive model systems to investigate
protein folding. The folding of both InlB [19,20,34] and
BA
Figure 3 Binding of YopM-InlB to MET. (A) Elution profiles from
gel filtration are shown for the complete MET ectodomain, for wild
type InlB321, for YopM-InlB and the respective complexes. Wild type
InlB321 is quantitatively shifted into a complex with MET eluting earlier
than the isolated MET ectodomain. In contrast, the elution volume of
YopM-InlB is only slightly shifted and its peak shows fronting indicating
low affinity binding to MET, the elution behaviour of which is virtually
unchanged. (B) Solid-phase binding assay, in which the complete MET
ectodomain (MET928) was immobilized on ELISA plates and incubated
with increasing concentrations of GST-tagged InlB321 and GST-tagged
YopM-InlB. Binding was detected with a horseradish peroxidase-coupled
anti-GST antibody. Three independent experiments, in which each
protein was tested in triplicate, were normalized and then averaged.
Error bars show standard deviation.
Table 2 Elution volume from gel filtration and calculated
molecular mass
Elution volume (ml) Calculated Mr (kDa)
MET928 10.86 207.7
InlB321 14.46 36.7
YopM-InlB 14.71 32.5
MET928 + InlB321 10.54 242.3
MET928 + YopM-InlB 10.83/14.53 210.7/35.5
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sion proteins like the one presented here that combine
the N-terminal cap domain of one with the LRR domain
of the other protein might represent new opportunities
to address the importance of the N-cap for folding.
Conclusions
The aim of this work was to replace the endogenous
N-terminal cap structure of InlB by a structurally unrelated
capping unit from another LRR protein in order to separ-
ate its structural role as folding nucleus from a potential
role as binding site for an interaction partner. Conceptu-
ally, this aim was reached. The designed hybrid protein
was folded and stable as shown by DSF, the single sym-
metric peak in gel filtration and the high-resolution crystal
structure. In this particular case, the hybrid protein was
not ideally suited for the intended functional studies, be-
cause it had reduced affinity for its receptor MET. Hence,
the interpretation of results from cellular assays is not
straightforward. However, our approach is not limited to
InlB but can similarly be applied to other internalins and
related LRR proteins.
Methods
Cloning of YopM-InlB
The cap domain together with the first LRR of Yersinia
enterocolitica YopM was amplified from the 70 kilo base
pair virulence plasmid pYVe227 with the primers
aggagc|catgggcAAATCTAAGGCTGAATATTATAATGC
(forward) and aggagg|aattccCGGCAAAGAACTCAGCC
(reverse). The resulting PCR fragment contains the se-
quence for YopM amino acids Lys34 to Pro87 with two
additional N-terminal residues (Met-Gly) due to the re-
striction site NcoI. The PCR fragment cleaved with NcoI
and EcoRI was ligated into the vector pETM30-InlB321
(HN04-15) that had been cleaved with the same enzymes
(removing amino acids 36 – 92 of InlB, which comprise
the cap and most of LRR1) to yield the vector pETM30-
YopM-InlB (HN06-01). The plasmid encoding YopM-
InlB-fl was generated by excising an EcoRI/NotI fragment
from the vector pGEX-6P-1-InlB-fl and cloning this into
pETM30-YopM-InlB (HN06-01) to yield pETM30-YopM-
InlB-fl (HN06-05).
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Figure 4 Biological activity of YopM-InlB and of YopM-InlB-fl.
(A) The ability of the YopM-InlB to induce ERK phosphorylation was
tested in Vero cells. Hepatocyte growth factor/scatter factor (HGF/SF)
was used as positive control. InlB241 was used as negative control.
The controls and reference in this figure (lane 1–6) are the same as
those shown in a previously published experiment with InlB321 with
an additional LRR inserted (Figure five c in [21]) as the experiments
with both InlB cap variants (YopM-InlB and InlB321 + 1LRRa) were
carried out in parallel. (B) The ability of YopM-InlB-fl to induce cell
motility was tested in an MDCK cell colony scatter assay. HGF/SF
was used as positive control, medium without ligand as negative
control. YopM-InlB-fl stimulated colony dispersal at a concentration
of 1 nM but showed no activity at 100 pM. The wild type protein
was active at 10-fold lower concentration
Breitsprecher et al. BMC Structural Biology 2014, 14:12 Page 7 of 9
http://www.biomedcentral.com/1472-6807/14/12Protein expression and purification
All variants of InlB were produced as GST-fusions and
purified essentially as described [15,21,27]. Briefly, E. coli
BL21 (DE3) CodonPlus RIL cells were grown with shaking
to an OD600 of 0.6 in LB medium at 37°C, shifted to 20°C,
induced with 1 mM IPTG and further incubated over
night. Harvested cells were resuspended in phosphate-
buffered saline (PBS) with benzonase and complete prote-
ase inhibitor cocktail (Roche) and lysed in a French Press.
After centrifugation the cleared lysate was applied to
glutathione sepharose (GE Healthcare), followed by thor-
ough washing with PBS. Fusion proteins used for ELISAs
were eluted with reduced glutathione and further purified
by anion exchange chromatography or size exclusion
chromatography if necessary. Proteins used for assays with
cells and for crystallization were cleaved from the GST-tag
using tobacco etch virus (TEV) protease and further puri-
fied by cation exchange chromatography or size exclusion
chromatography or both.Crystallization, data collection and structure determination
Initial crystals of YopM-InlB were obtained in sitting drops
with a volume of 200 nl from Nextal screen MbClass in
condition 42. Plate-shaped crystals for data collection were
grown by hanging drop vapour diffusion at 20°C with a
drop size of 2 μl consisting of equal volumes of protein at a
concentration of 10 mg/ml and reservoir solution (0.1 M
Tricine, pH 9.0, 28% PEG 1000, 10% glycerol, 0.25 M KCl).
Crystals were cryo-protected with reservoir-solution add-
itionally containing 15% glycerol and flash-frozen in liquid
nitrogen. Data were collected on a MAR-CCD 165 detector
at beamline X13, EMBL Hamburg, indexed and integrated
with XDS, and scaled with XSCALE [38]. The phase prob-
lem was solved by molecular replacement using the pro-
gram Phaser [39] with the appropriate fragments of InlB
and YopM as search models. Errors were corrected and
missing residues were added manually in the program Coot
[40]. The structure was refined in the program REFMAC5
[41] using TLS groups suggested by the TLS motion
detection server [42] and checked with MolProbity
[43]. Data collection and refinement statistics are given
in Table 1. Structural alignments were performed with
LSQKAB [44]. Figures were prepared with PyMol [45].
Coordinates and structure factors were deposited in
the PDB under accession code 4cil.Differential scanning fluorimetry
DSF was carried out essentially as described [46]. Pro-
teins were measured at 0.1 mg/ml in PBS with a 1×
SYPRO Orange concentration from 26°C to 95°C. The
experiment was repeated four times with at least four
data points for each protein and experiment. Data were
analysed following a published protocol [47].
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40 μg of the complete MET ectodomain (MET928), equi-
molar amounts of wild type InlB321 or YopM-InlB or the
respective mixtures were run on a Superdex200 10/300
GL column (GE Healthcare) equilibrated in PBS.
Binding, phosphorylation and cell scatter assays
Binding, phosphorylation and cell scatter assays were
carried out essentially as described [15]. The MET ecto-
domain (MET928) was purified from stably transfected
CHO cells [48].
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